Literature DB >> 9700525

Photodynamic antimicrobial chemotherapy (PACT).

M Wainwright1.   

Abstract

Whereas the photodynamic therapy (PDT) of cancer has recently shown rapid clinical acceptance, photodynamic antimicrobial chemotherapy (PACT)--which predates the related cancer regimen--is not widely appreciated. Like PDT, PACT utilizes photosensitizers and visible or ultraviolet light in order to give a phototoxic response, normally via oxidative damage. Currently, the major use of PACT is in the disinfection of blood products, particularly for viral inactivation, although more clinically-based protocols are being developed, e.g. in the treatment of oral infection. The technique has been shown to be effective in vitro against bacteria (including drug-resistant strains), yeasts, viruses and parasites. A wide range of photosensitizers, both natural and synthetic, is available with differing physicochemical make-up and light-absorption properties. PACT is proposed as a potential, low-cost approach to the treatment of locally occurring infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700525     DOI: 10.1093/jac/42.1.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  206 in total

Review 1.  Antibiotic resistance: a current perspective.

Authors:  K F Barker
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Photodynamic therapy.

Authors:  D C Shackley; C Whitehurst; N W Clarke; C Betts; J V Moore
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

3.  Photoactive porphyrin derivative with broad-spectrum activity against oral pathogens In vitro.

Authors:  C R Rovaldi; A Pievsky; N A Sole; P M Friden; D M Rothstein; P Spacciapoli
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  Fungicidal activity of khlorin photosensitizers.

Authors:  M G Strakhovskaya; V G Zhukhovitskii; A F Mironov; A M Seregin; E F Stranadko; A B Rubin
Journal:  Dokl Biochem Biophys       Date:  2002 May-Jun       Impact factor: 0.788

5.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

6.  Targeted photodynamic therapy of established soft-tissue infections in mice.

Authors:  Faten Gad; Touqir Zahra; Kevin P Francis; Tayyaba Hasan; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2004-02-11       Impact factor: 3.982

7.  Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria.

Authors:  Faten Gad; Touqir Zahra; Tayyaba Hasan; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  Bioluminescent genetically transformed bacteria as a new effective tool for testing photosensitization activity.

Authors:  M G Strakhovskaya; A P Zarubina; V G Zhukhovitskii; A F Mironov; A B Rubin
Journal:  Dokl Biochem Biophys       Date:  2004 May-Jun       Impact factor: 0.788

9.  Multiresistant strains are as susceptible to photodynamic inactivation as their naïve counterparts: protoporphyrin IX-mediated photoinactivation reveals differences between methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains.

Authors:  Mariusz Grinholc; Aleksandra Rapacka-Zdonczyk; Bartosz Rybak; Florian Szabados; Krzysztof P Bielawski
Journal:  Photomed Laser Surg       Date:  2014-02-14       Impact factor: 2.796

10.  The agr function and polymorphism: impact on Staphylococcus aureus susceptibility to photoinactivation.

Authors:  Mariusz Grinholc; Joanna Nakonieczna; Alessandro Negri; Aleksandra Rapacka-Zdonczyk; Agata Motyka; Grzegorz Fila; Julianna Kurlenda; Justyna Leibner-Ciszak; Michael Otto; Krzysztof P Bielawski
Journal:  J Photochem Photobiol B       Date:  2013-10-23       Impact factor: 6.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.